Gelatin-based nanoparticle targets molecular 'seesaw' behind lung cancer drug resistance
Wednesday, July 9, 2025 - 04:06
in Health & Medicine
A fundamental discovery by University of Missouri scientists could help solve one of the most frustrating challenges in treating lung cancer: Why do some patients initially respond to drug treatment, only for it to stop working 18 months later?